Stratec SE (ETR:SBS)

Market Cap	297.21M
Revenue (ttm)	250.54M
Net Income (ttm)	10.01M
Shares Out	12.16M
EPS (ttm)	0.82
PE Ratio	29.82
Forward PE	16.02
Dividend	0.55 (2.25%)
Ex-Dividend Date	May 20, 2024

Volume	7,294
Average Volume	11,840
Open	23.85
Previous Close	24.00
Day's Range	23.60 - 24.60
52-Week Range	21.00 - 48.60
Beta	0.44
RSI	47.87
Earnings Date	Apr 29, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headqu...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2018
• Employees: 1,480
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SBS

Financial Performance

In 2023, Stratec SE's revenue was 261.91 million, a decrease of -4.63% compared to the previous year's 274.63 million. Earnings were 13.07 million, a decrease of -55.29%.